A Novel Wogonin Derivative Induces Apoptosis in PC-3M Cells by Targeting Mitochondrial Dysfunction and Activating the ROS-p38/MAPK Pathway
Molecules · 05.03.2026 · 31 (5) · 859
DOI: 10.3390/molecules31050859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 05.03.2026. Verfasst von Dingrui Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, China. Hauptthemen laut MEDLINE: Flavanones, Apoptosis, Reactive Oxygen Species, Mitochondria. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Natural Science Foundation of Jilin Province, Project of the Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Current cancer treatments have significant limitations. Designing TPP+-modified, mitochondrial-targeted drugs can improve anticancer efficacy. Although wogonin exhibits antitumor activity, it has drawbacks, including poor solubility and limited distribution. This study designed and synthesized 27 derivatives, including nine novel wogonin triphenylphosphine derivatives that demonstrated in vitro antitumor activity. Mito-WO-8, one of these derivatives, exhibited potent activity against PC-3M cells (IC50 = 3.19 μmol/L), demonstrating 15-fold higher potency than wogonin. Further analysis revealed that Mito-WO-8 accumulates more in mitochondria than wogonin and induces mitochondrial dysfunction, including increased reactive oxygen species, reduced membrane potential, and activation of the MPTP channel. Transcriptome and network analyses revealed that Mito-WO-8 activates the p38/MAPK pathway. Downregulation of p-MKK6 and p-p38, as well as upregulation of DDIT3 and cleaved caspase-3, were validated by Western blot (WB) and quantitative polymerase chain reaction (qPCR). Therefore, Mito-WO-8 enhances mitochondrial enrichment and induces mitochondrial damage. This process is associated with apoptosis and the activation of the ROS-p38/MAPK pathway. Additionally, the study found that Mito-WO-8 exhibits a stronger binding affinity for mitochondrial glycerol-3-phosphate dehydrogenase 2 (GPD2) than the parent compound (−9.6 kJ/mol vs. −6.6 kJ/mol), suggesting a potential interaction with GPD2. This finding establishes a foundation for further investigation into its targeted antitumor mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicinal Material, Jilin Agricultural University, 2888 Xincheng Street, Changchun 130118, China.
ORCID-Profile: Dingrui Liu, Wei Li, Yan Zhao, Enbo Cai
Förderung
- Project of Natural Science Foundation of Jilin Province
- Project of the Natural Science Foundation of Jilin Province
Zitieren
APA
Liu, D., Liu, F., Song, M., Su, F., Li, W., Zhao, Y., Han, J., & Cai, E. (2026). A Novel Wogonin Derivative Induces Apoptosis in PC-3M Cells by Targeting Mitochondrial Dysfunction and Activating the ROS-p38/MAPK Pathway. Molecules, 31(5), 859. https://doi.org/10.3390/molecules31050859
Vancouver
Liu D, Liu F, Song M, Su F, Li W, Zhao Y, et al. A Novel Wogonin Derivative Induces Apoptosis in PC-3M Cells by Targeting Mitochondrial Dysfunction and Activating the ROS-p38/MAPK Pathway. Molecules. 2026;31(5):859. doi:10.3390/molecules31050859
BibTeX
@article{Liu2026,
author = {Liu, Dingrui and Liu, Fangfei and Song, Mingjie and Su, Fengyan and Li, Wei and Zhao, Yan and Han, Jiahong and Cai, Enbo},
title = {A Novel Wogonin Derivative Induces Apoptosis in PC-3M Cells by Targeting Mitochondrial Dysfunction and Activating the ROS-p38/MAPK Pathway},
journal = {Molecules},
year = {2026},
volume = {31},
number = {5},
pages = {859},
doi = {10.3390/molecules31050859}
}
EUVIMED